Home › Medicines › Cogniz
Cogniz

Cogniz

Tablet

🧬 Citicoline Sodium 🏢 UniMed UniHealth Pharmaceuticals Ltd.
Generic Name Citicoline Sodium
Manufacturer UniMed UniHealth Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 50.00 (3 x 10: ৳ 1,500.00) Strip Price: ৳ 500.00

🔹 Indications

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pharmacology

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Dosage & Administration

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Interaction

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Contraindications

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Side Effects

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pregnancy & Lactation

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Precautions & Warnings

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pediatric Usage

Information not available in English.

🔹 Storage Conditions

Cogniz is indicated in-
  • Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
  • Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
  • Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
  • Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

💡 Frequently Asked Questions

Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...
Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...
Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Citicol IM/IV Injection

Beximco Pharmaceuticals Ltd.

4 ml ampoule: ৳ 140.00 (1 x 5: ৳ 700.00)